Table of Contents Author Guidelines Submit a Manuscript
Advances in Virology
Volume 2015 (2015), Article ID 936940, 12 pages
http://dx.doi.org/10.1155/2015/936940
Review Article

Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals

Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Serdang, Malaysia

Received 29 May 2015; Accepted 26 July 2015

Academic Editor: Jay C. Brown

Copyright © 2015 Pit Sze Liew and Mohd Hair-Bejo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. S. Lau and S. S. M. Sun, “Plant seeds as bioreactors for recombinant protein production,” Biotechnology Advances, vol. 27, no. 6, pp. 1015–1022, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Walmsley and C. J. Arntzen, “Plants for delivery of edible vaccines,” Current Opinion in Biotechnology, vol. 11, no. 2, pp. 126–129, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. E. P. Rybicki, “Plant-produced vaccines: promise and reality,” Drug Discovery Today, vol. 14, no. 1-2, pp. 16–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Santi, “Plant derived veterinary vaccines,” Veterinary Research Communications, vol. 33, no. 1, supplement, pp. S61–S66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Joensuu, V. Niklander-Teeri, and J. E. Brandle, “Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control,” Phytochemistry Reviews, vol. 7, no. 3, pp. 553–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Spök, R. M. Twyman, R. Fischer, J. K. C. Ma, and P. A. C. Sparrow, “Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants,” Trends in Biotechnology, vol. 26, no. 9, pp. 506–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. G. A. De Zoeten, J. R. Penswick, M. A. Horisberger, P. Ahl, M. Schultze, and T. Hohn, “The expression, localization, and effect of a human interferon in plants,” Virology, vol. 172, no. 1, pp. 213–222, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Hiatt, R. Cafferkey, and K. Bowdish, “Production of antibodies in transgenic plants,” Nature, vol. 342, no. 6245, pp. 76–78, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. P. C. Sijmons, B. M. M. Dekker, B. Schrammeijer, T. C. Verwoerd, P. J. M. Van Den Elzen, and A. Hoekema, “Production of correctly processed human serum albumin in transgenic plants,” Nature Biotechnology, vol. 8, no. 3, pp. 217–221, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pujol, N. I. Ramírez, M. Ayala et al., “An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification,” Vaccine, vol. 23, no. 15, pp. 1833–1837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. K.-C. Ma, E. Barros, R. Bock et al., “Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants,” EMBO Reports, vol. 6, no. 7, pp. 593–599, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. E. E. Hood, D. R. Witcher, S. Maddock et al., “Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification,” Molecular Breeding, vol. 3, no. 4, pp. 291–306, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. D. R. Witcher, E. E. Hood, D. Peterson et al., “Commercial production of β-glucuronidase (GUS): a model system for the production of proteins in plants,” Molecular Breeding, vol. 4, no. 4, pp. 301–312, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Woodard, J. M. Mayor, M. R. Bailey et al., “Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants,” Biotechnology and Applied Biochemistry, vol. 38, no. 2, pp. 123–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. H. S. Mason, D. M.-K. Lam, and C. J. Arntzen, “Expression of hepatitis B surface antigen in transgenic plants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11745–11749, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Kapusta, A. Modelska, M. Figlerowicz et al., “A plant-derived edible vaccine against hepatitis B virus,” The FASEB Journal, vol. 13, no. 13, pp. 1796–1799, 1999. View at Google Scholar · View at Scopus
  17. Y. Thanavala, M. Mahoney, S. Pal et al., “Immunogenicity in humans of an edible vaccine for hepatitis B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 9, pp. 3378–3382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. H. S. Mason, T. A. Haq, J. D. Clements, and C. J. Arntzen, “Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene,” Vaccine, vol. 16, no. 13, pp. 1336–1343, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. C. O. Tacket, M. F. Pasetti, R. Edelman, J. A. Howard, and S. Streatfield, “Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn,” Vaccine, vol. 22, no. 31-32, pp. 4385–4389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. H. S. Mason, J. M. Ball, J.-J. Shi, X. Jiang, M. K. Estes, and C. J. Arntzen, “Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 11, pp. 5335–5340, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Vermij and E. Waltz, “USDA approves the first plant-based vaccine,” Nature Biotechnology, vol. 24, no. 3, pp. 233–234, 2006. View at Publisher · View at Google Scholar
  22. J. K. Ma, “The caries vaccine: a growing prospect,” Dental Update, vol. 26, no. 9, pp. 374–380, 1999. View at Google Scholar · View at Scopus
  23. D. W. Pascual, “Vaccines are for dinner,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 10757–10758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Tregoning, P. Maliga, G. Dougan, and P. J. Nixon, “New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC,” Phytochemistry, vol. 65, no. 8, pp. 989–994, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. G. J. O'Brien, C. J. Bryant, C. Voogd, H. B. Greenberg, R. C. Gardner, and A. R. Bellamy, “Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles,” Virology, vol. 270, no. 2, pp. 444–453, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Huang, I. Dry, D. Webster, R. Strugnell, and S. Wesselingh, “Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice,” Vaccine, vol. 19, no. 15-16, pp. 2163–2171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. D. E. Webster, M. L. Cooney, Z. Huang et al., “Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine,” Journal of Virology, vol. 76, no. 15, pp. 7910–7912, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. L. McLain, Z. Durrani, L. A. Wisniewski, C. Porta, G. P. Lomonossoff, and N. J. Dimmock, “Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus,” Vaccine, vol. 14, no. 8, pp. 799–810, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. G. G. Zhang, L. Rodrigues, B. Rovinski, and K. A. White, “Production of HIV-1 p24 protein in transgenic tobacco plants,” Applied Biochemistry and Biotechnology—Part B Molecular Biotechnology, vol. 20, no. 2, pp. 131–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Meyers, E. Chakauya, E. Shephard et al., “Expression of HIV-1 antigens in plants as potential subunit vaccines,” BMC Biotechnology, vol. 8, no. 1, article 53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. S. Tackaberry, A. K. Dudani, F. Prior et al., “Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco,” Vaccine, vol. 17, no. 23-24, pp. 3020–3029, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Belanger, N. Fleysh, C. O. X. Shannon et al., “Human respiratory syncytial virus vaccine antigen produced in plants,” The FASEB Journal, vol. 14, no. 14, pp. 2323–2328, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. J. S. Sandhu, S. F. Krasnyanski, L. L. Domier, S. S. Korban, M. D. Osadjan, and D. E. Buetow, “Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response,” Transgenic Research, vol. 9, no. 2, pp. 127–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. F. R. Brennan, T. D. Jones, M. Longstaff et al., “Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses,” Vaccine, vol. 17, no. 15-16, pp. 1846–1857, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. F. R. Brennan, T. D. Jones, L. B. Gilleland et al., “Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus,” Microbiology, vol. 145, no. 1, pp. 211–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Staczek, M. Bendahmane, L. B. Gilleland, R. N. Beachy, and H. E. Gilleland Jr., “Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa,” Vaccine, vol. 18, no. 21, pp. 2266–2274, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. T. H. Turpen, S. J. Reinl, Y. Charoenvit, S. L. Hoffman, V. Fallarme, and L. K. Grill, “Malaria epitopes expressed on the surface of recombinant tobacco mosaic virus,” Nature Biotechnology, vol. 13, no. 1, pp. 53–57, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Sala, M. M. Rigano, A. Barbante, B. Basso, A. M. Walmsley, and S. Castiglione, “Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives,” Vaccine, vol. 21, no. 7-8, pp. 803–808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. D. M. Floss, D. Falkenburg, and U. Conrad, “Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview,” Transgenic Research, vol. 16, no. 3, pp. 315–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. M. Rigano and A. M. Walmsley, “Expression systems and developments in plant-made vaccines,” Immunology and Cell Biology, vol. 83, no. 3, pp. 271–277, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. H. S. Mason, H. Warzecha, T. Mor, and C. J. Arntzen, “Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine,” Trends in Molecular Medicine, vol. 8, no. 7, pp. 324–329, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Giddings, “Transgenic plants as protein factories,” Current Opinion in Biotechnology, vol. 12, no. 5, pp. 450–454, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Mett, C. E. Farrance, B. J. Green, and V. Yusibov, “Plants as biofactories,” Biologicals, vol. 36, no. 6, pp. 354–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. C. Muskett, N. E. Reed, and D. H. Thornton, “Increased virulence of an infectious bursal disease live virus vaccine after passage in chicks,” Vaccine, vol. 3, no. 4, pp. 309–312, 1985. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Zavala and S. Cheng, “Detection and characterization of avian leukosis virus in Marek's disease vaccines,” Avian Diseases, vol. 50, no. 2, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. S. J. Streatfield and J. A. Howard, “Plant-based vaccines,” International Journal for Parasitology, vol. 33, no. 5-6, pp. 479–493, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. I. B. H. Wilson, “Glycosylation of proteins in plants and invertebrates,” Current Opinion in Structural Biology, vol. 12, no. 5, pp. 569–577, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. S. A. Brooks, “Appropriate glycosylation of recombinant proteins for human use,” Molecular Biotechnology, vol. 28, no. 3, pp. 241–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Saint-Jore-Dupas, L. Faye, and V. Gomord, “From planta to pharma with glycosylation in the toolbox,” Trends in Biotechnology, vol. 25, no. 7, pp. 317–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Fischer, E. Stoger, S. Schillberg, P. Christou, and R. M. Twyman, “Plant-based production of biopharmaceuticals,” Current Opinion in Plant Biology, vol. 7, no. 2, pp. 152–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. Arabidopsis Genome Initiative, “Analysis of the genome sequence of the flowering plant Arabidopsis thaliana,” Nature, vol. 408, pp. 796–815, 2000. View at Google Scholar
  52. H. Daniell, S. J. Streatfield, and K. Wycoff, “Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants,” Trends in Plant Science, vol. 6, no. 5, pp. 219–226, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. R. M. Twyman, E. Stoger, S. Schillberg, P. Christou, and R. Fischer, “Molecular farming in plants: host systems and expression technology,” Trends in Biotechnology, vol. 21, no. 12, pp. 570–578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Lerouge, M. Cabanes-Macheteau, C. Rayon, A.-C. Fischette-Lainé, V. Gomord, and L. Faye, “N-glycoprotein biosynthesis in plants: recent developments and future trends,” Plant Molecular Biology, vol. 38, no. 1-2, pp. 31–48, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Gomord, A.-C. Fitchette, L. Menu-Bouaouiche et al., “Plant-specific glycosylation patterns in the context of therapeutic protein production,” Plant Biotechnology Journal, vol. 8, no. 5, pp. 564–587, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Bardor, C. Loutelier-Bourhis, T. Paccalet et al., “Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures,” Plant Biotechnology Journal, vol. 1, no. 6, pp. 451–462, 2003. View at Publisher · View at Google Scholar
  57. J.-Y. Zhou, J.-X. Wu, L.-Q. Cheng et al., “Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes,” Journal of Virology, vol. 77, no. 16, pp. 9090–9093, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J.-Y. Zhou, L.-Q. Cheng, X.-J. Zheng et al., “Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus,” Journal of Biotechnology, vol. 111, no. 2, pp. 121–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. K. S. Gunn, N. Singh, J. Giambrone, and H. Wu, “Using transgenic plants as bioreactors to produce edible vaccines,” Journal of Biotech Research, vol. 4, no. 1, pp. 92–99, 2012. View at Google Scholar · View at Scopus
  60. P. B. McGarvey, J. Hammond, M. M. Dienelt et al., “Expression of the rabies virus glycoprotein in transgenic tomatoes,” Nature Biotechnology, vol. 13, no. 13, pp. 1484–1487, 1995. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Saldaña, F. E. Guadarrama, T. D. J. Olivera Flores et al., “Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies,” Viral Immunology, vol. 19, no. 1, pp. 42–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Boothe, C. Nykiforuk, Y. Shen et al., “Seed-based expression systems for plant molecular farming,” Plant Biotechnology Journal, vol. 8, no. 5, pp. 588–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Stöger, C. Vaquero, E. Torres et al., “Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies,” Plant Molecular Biology, vol. 42, no. 4, pp. 583–590, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Nochi, H. Takagi, Y. Yuki et al., “Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 10986–10991, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Ramessar, M. Sabalza, T. Capell, and P. Christou, “Maize plants: an ideal production platform for effective and safe molecular pharming,” Plant Science, vol. 174, no. 4, pp. 409–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. S. J. Streatfield, J. M. Jilka, E. E. Hood et al., “Plant-based vaccines: unique advantages,” Vaccine, vol. 19, no. 17–19, pp. 2742–2748, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. B. J. Lamphear, J. M. Jilka, L. Kesl, M. Welter, J. A. Howard, and S. J. Streatfield, “A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine,” Vaccine, vol. 22, no. 19, pp. 2420–2424, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Guerrero-Andrade, E. Loza-Rubio, T. Olivera-Flores, T. Fehérvári-Bone, and M. A. Gómez-Lim, “Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies,” Transgenic Research, vol. 15, no. 4, pp. 455–463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Wu, L. Yu, L. Li, J. Hu, J. Zhou, and X. Zhou, “Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens,” Plant Biotechnology Journal, vol. 5, no. 5, pp. 570–578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. J. J. Joensuu, M. Kotiaho, T. H. Teeri et al., “Glycosylated F4 (K88) fimbrial adhesin FaeG expressed in barley endosperm induces ETEC-neutralizing antibodies in mice,” Transgenic Research, vol. 15, no. 3, pp. 359–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Moravec, M. A. Schmidt, E. M. Herman, and T. Woodford-Thomas, “Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine,” Vaccine, vol. 25, no. 9, pp. 1647–1657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Stoger, J. K.-C. Ma, R. Fischer, and P. Christou, “Sowing the seeds of success: pharmaceutical proteins from plants,” Current Opinion in Biotechnology, vol. 16, no. 2, pp. 167–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Dalsgaard, Å. Uttentha, T. D. Jones et al., “Plant-derived vaccine protects target animals against a viral disease,” Nature Biotechnology, vol. 15, no. 3, pp. 248–252, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Castañón, M. S. Marín, J. M. Martín-Alonso et al., “Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus,” Journal of Virology, vol. 73, no. 5, pp. 4452–4455, 1999. View at Google Scholar · View at Scopus
  75. J. M. Martín-Alonso, S. Castañón, P. Alonso, F. Parra, and R. Ordás, “Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein,” Transgenic Research, vol. 12, no. 1, pp. 127–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. C.-D. Yang, J.-T. Liao, C.-Y. Lai et al., “Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes,” BMC Biotechnology, vol. 7, no. 1, article 62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. T.-H. Chen, T.-H. Chen, C.-C. Hu et al., “Induction of protective immunity in chickens immunized with plant-made chimeric bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen,” Virus Research, vol. 166, no. 1-2, pp. 109–115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. E. Gómez, M. S. Lucero, S. Chimeno Zoth, J. M. Carballeda, M. J. Gravisaco, and A. Berinstein, “Transient expression of VP2 in Nicotiana benthamiana and its use as a plant-based vaccine against infectious bursal disease virus,” Vaccine, vol. 31, no. 23, pp. 2623–2627, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. B. J. Lamphear, S. J. Streatfield, J. M. Jilka et al., “Delivery of subunit vaccines in maize seed,” Journal of Controlled Release, vol. 85, no. 1–3, pp. 169–180, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. J. A. Howard, “Commercialization of plant-based vaccines from research and development to manufacturing.,” Animal Health Research Reviews, vol. 5, no. 2, pp. 243–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Carrillo, A. Wigdorovitz, J. C. Oliveros et al., “Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants,” Journal of Virology, vol. 72, no. 2, pp. 1688–1690, 1998. View at Google Scholar · View at Scopus
  82. A. Wigdorovitz, C. Carrillo, M. J. Dus Santos et al., “Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1,” Virology, vol. 255, no. 2, pp. 347–353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. M. J. D. Santos, A. Wigdorovitz, K. Trono et al., “A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants,” Vaccine, vol. 20, no. 7-8, pp. 1141–1147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. C. Carrillo, A. Wigdorovitz, K. Trono et al., “Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants,” Viral Immunology, vol. 14, no. 1, pp. 49–57, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Wigdorovitz, D. M. Pérez Filgueira, N. Robertson et al., “Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1,” Virology, vol. 264, no. 1, pp. 85–91, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Nick, D. Cursiefen, and H. Becht, “Structural and growth characteristics of infectious bursal disease virus,” Journal of Virology, vol. 18, no. 1, pp. 227–234, 1976. View at Google Scholar · View at Scopus
  87. H. Wu, N. K. Singh, R. D. Locy, K. Scissum-Gunn, and J. J. Giambrone, “Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana,” Biotechnology Letters, vol. 26, no. 10, pp. 787–792, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. H. S. Mason and M. M. Herbst-Kralovetz, “Plant-derived antigens as mucosal vaccines,” Current Topics in Microbiology and Immunology, vol. 354, no. 1, pp. 101–120, 2012. View at Publisher · View at Google Scholar · View at Scopus